Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 19, 2017
Pharmacy Choice - News - Front Page Healthcare News - October 19, 2017

Pharmacy News

 Front Page Healthcare News
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

9/18/17 - "Method for the Production and Filling of an Application Package for a Liquid Pharmaceutical Product" in Patent Application Approval Process (USPTO...
"Method for the Production and Filling of an Application Package for a Liquid Pharmaceutical Product" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors Klocke, Hartmut; Renner, Klaus, filed on February 29, 2016, was made available online on September 7, 2017,
9/18/17 - "Pharmaceutical Preparations for Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder and Other Associated Disorders" in Patent...
"Pharmaceutical Preparations for Attention Deficit Disorder, Attention Deficit Hyperactivity Disorder and Other Associated Disorders" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Mental Health Weekly Digest A patent application by the inventor Fallon, Joan M., filed on November 17, 2016, was made available onlin
9/18/17 - "Production Method for 3,3-Dimethyl-3,4-Dihydro-1h-Quinoxalin-2-One Derivative and Intermediate for Said Production Method" in Patent Application...
"Production Method for 3,3- Dimethyl-3, 4- Dihydro-1h-Quinoxalin-2-One Derivative and Intermediate for Said Production Method" in Patent Application Approval Process. By a News Reporter-Staff News Editor at Pharma Business Week A patent application by the inventors KUDOU, Kazuhiro; NAGATSUKA, Masato, filed on May 12, 2017, was made available onli
9/18/17 - 12 Biggest Mid-Day Gainers For Monday
Nabriva Therapeutics plc shares jumped 88.2 percent to $12.91 after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints. Silver Spring Networks Inc climbed 23.9 percent to $16.10. Itron, Inc. announced plans to acquire Silver Spring Networks for $16.25 per share. Orbital ATK Inc shares
9/18/17 - 22 Stocks Moving In Monday's Pre-Market Session
Gainers Nabriva Therapeutics plc rose 84.4 percent to $12.65 in pre-market trading after the company disclosed that its Phase 3 trial evaluating IV and oral lefamulin met all primary FDA and EMA endpoints. Silver Spring Networks Inc rose 23.1 percent to $16.00 in pre-market trading. Itron, Inc. announced plans to acquire Silver Spring Networks for
9/18/17 - 3D Communications Contributes to New Edition of RAPS' Essential Regulatory Affairs Text Book
By a News Reporter-Staff News Editor at Biotech Business Week The Regulatory Affairs Professionals Society has just published the updated 10th tenth edition of its popular text, Fundamentals of US Regulatory Affairs, the most extensive reference available on regulatory affairs for pharmaceuticals, medical devices, biologics and other healthcare..
9/18/17 - 5 Stocks To Watch For September 18, 2017
Wall Street expects Steelcase Inc. to post quarterly earnings at $0.23 per share on revenue of $759.83 million after the closing bell. Steelcase shares gained 1.79 percent to close at $14.25 on Friday. Neos Therapeutics Inc disclosed that it has received the FDA approval for Adzenys ER. Scorpio Tankers shares dropped 2.23 percent to close at $3.50
9/18/17 - AbbVie Announces Positive Topline Results from Phase 3 Trial Evaluating VENCLEXTA?/VENCLYXTO? (Venetoclax) Tablets in Combination with Rituxan (rituximab) for the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
AbbVie, a global research and development-based biopharmaceutical company, today announced that the Phase 3 MURANO study of VENCLEXTA?/ VENCLYXTO? Tablets in combination with Rituxan met its primary endpoint. Doctors will continue to monitor patients who remain active in the MURANO trial in efforts to obtain additional, longer-term safety
9/18/17 - AbbVie Submits New Drug Application to U.S. FDA for Investigational Oral Treatment Elagolix for the Management of Endometriosis with Associated Pain
By a News Reporter-Staff News Editor at Pharma Business Week AbbVie, a research and development based global biopharmaceutical company in cooperation with Neurocrine Biosciences, Inc., announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for elagolix, an investigational, orally administered...
9/18/17 - ABIVAX: First Patient Dosed in Three-Month Cohort of Phase 2a Study of Oral ABX464 in HIV-Suppressed Patients
ABIVAX, an innovative biotechnology company targeting the immune system to eliminate viral diseases using its unique antiviral technology platform, today announced that the first patient has been dosed in the second cohort of the Phase 2 a ABX464-005 clinical trial. ABX464-005 is a Phase 2 a trial studying the effects of ABX464 on HIV reservoirs an
9/18/17 - ACROSS THE STATE
Howard Gamble, administrator of the Wheeling- Ohio County Health Department, said the state allocation to the department is $254,157 this year will be down about $10,000 from last year. The U.S. Census Bureau's American Community Survey shows 88,351 children under 18 years old in poverty, or 24 percent of those living in West Virginia in 2016..
9/18/17 - Advanced Bifurcation Systems to Sponsor XIII European Bifurcation Club Meeting
Advanced Bifurcation Systems, a clinical stage medical device company developing an innovative stenting platform which overcomes the limitations of current approaches for the treatment of bifurcation lesions in coronary angioplasties, today announced that the Company will be a sponsor of the XIII European Bifurcation Club meeting at the Casa Das.
9/18/17 - Advanced Home Care supports nonprofits [The High Point Enterprise, N.C.]
Sept. 18 HIGH POINT Advanced Home Care has donated $90,000 to three nonprofits in areas across the Piedmont Triad and state served by the home health care provider. The donations stemmed from Advanced Home Care's 24th annual Charity Golf Classic and sponsors. Advanced Home Care partnered with three healthcare systems with an ownership stake in
9/18/17 - Alnylam Provides Pipeline Update on Fitusiran and Givosiran Investigational RNAi Therapeutic Programs
By a News Reporter-Staff News Editor at Clinical Trials Week Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced an update on the company's fitusiran and givosiran investigational RNAi therapeutic programs. With givosiran, an RNAi therapeutic in development for the treatment of acute hepatic porphyrias, Alnylam has rea
9/18/17 - Ampio Completes Enrollment of Patients in 12-Week Pivotal Trial
Ampio Pharmaceuticals, Inc. announces the completion of enrollment and dosing of patients in their pivotal single injection study on the "unmet medical need" of severe osteoarthritis of the knee. Regulatory Exclusivity and IP protection: The Company believes that Ampion?, a low molecular weight fraction of human serum albumin with anti-inflamma
9/18/17 - AmpliPhi Biosciences CEO to Moderate Panel Discussion at Upcoming Anti-Infectives Rx Conference
AmpliPhi Biosciences Corporation, a clinical-stage biotechnology company focused on the development of therapies for antibiotic-resistant infections using bacteriophage technology, announces that CEO Paul C. Grint, M.D., will moderate a panel titled, Advances Against Rare and Resistant Pathogens at the Anti-Infectives Rx Conference to be held
9/18/17 - An Application for the Trademark "MEDA PHARMACEUTICALS" Has Been Filed by Mylan
By a News Reporter-Staff News Editor at Clinical Trials Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "MEDA PHARMACEUTICALS" by Mylan Inc.- Trademarks, representing Mylan. This application was made available to the public on September 06, 2017. The serial numbe
9/18/17 - Animal Stem Cell Therapy Market 2017 Global In-Depth Investigation and Analysis Report to 2022
WiseGuyReports.Com Publish a New Market Research Report On- "Animal Stem Cell Therapy Market 2017 Global In-Depth Investigation and Analysis Report to 2022". This report studies the global Animal Stem Cell Therapy market, analyzes and researches the Animal Stem Cell Therapy development status and forecast in United States, EU, Japan, China, India a
9/18/17 - ASNC and ASE Team Up to Expand the ImageGuide Registry
The American Society of Nuclear Cardiology and the American Society of Echocardiography jointly announced at ASNC's 22nd Annual Scientific Sessions a partnership to develop an ASE Echocardiography Module to expand ASNC's ImageGuide Registry?. The Echo Module, ImageGuideEcho?, will continue the registry's mission to harness the power of patient
9/18/17 - ASTROTECH CORP - 10-K - Management's Discussion and Analysis of Financial Condition and Results of Operations.
Astrotech Corporation, a Washington corporation organized in 1984, is an innovative science and technology development and commercialization company that invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions, and then funds, manages, and builds start-up.
9/18/17 - Asymchem Dunhua Manufacturing Facility Successfully Completes US FDA Pre-Approval Inspection
By a News Reporter-Staff News Editor at Pharma Business Week Asymchem Laboratories Co., Ltd. announced that its API facility in Dunhua city, Jilin province, P. R. China, has successfully passed a pre-approval inspection by the US Food and Drug Administration. Previous PAI and cGMP inspections by the US FDA were conducted in 2014 at Asymchem's Tia
9/18/17 - At CAGR 12%, Global Anaesthesia Monitoring Device Market Showing Impressive Growth Forecast for Period 2016-2023: Occams Business Research & Consulting Pvt. Ltd.
Food and Drug Administration defines anaesthesia as a reversible state of unconsciousness resulting in lack of pain and muscle relaxation. Anaesthesia monitoring devices, multi parameter patient monitors are used to gauge patient's response on administered anaesthetic drug during surgery. According to National Centre for Biotechnology Information..
9/18/17 - Autolus commences clinical trial programmes
Syncona Limited Autolus commences clinical trial programmes 18 September 2017 Syncona Ltd, a leading healthcare company focused on investing in and building global leaders in life science, today notes that its portfolio company, Autolus, which is developing and commercialising next-generation engineered T-cell therapies to combat cancer, has...
9/18/17 - Avery Therapeutics Inc. to be honored with an AZBio Fast Lane Award
By a News Reporter-Staff News Editor at Clinical Trials Week The Arizona Bioindustry Association will honor Avery Therapeutics Inc. with an AZBio Fast Lane Award at the 2017 AZBio Awards. Arizona life science and business leaders as well as guests from across the country will be on hand to applaud the Avery Therapeutics team for their progress in
9/18/17 - Berg & Androphy: $46.5M Settlement in False Claims Act Case Over Alleged Illegal Marketing of Novo Nordisk Diabetes Drug Victoza
By a News Reporter-Staff News Editor at Pharma Business Week Joel M. Androphy and Sarah M. Frazier of the Berg& Androphy law firm, along with the U.S. Department of Justice and 50 state Medicaid programs plus the District of Columbia and the City of Chicago, have reached settlements in False Claims Act litigation against Novo Nordisk and their su
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415